- Home
- ROIV vs XP Comparison
ROIV vs XP Comparison
Compare ROIV & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- XP
- Stock Information
- Founded
- ROIV 2014
- XP 2001
- Country
- ROIV United Kingdom
- XP Cayman Islands
- Employees
- ROIV N/A
- XP N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- XP Investment Bankers/Brokers/Service
- Sector
- ROIV Health Care
- XP Finance
- Exchange
- ROIV Nasdaq
- XP Nasdaq
- Market Cap
- ROIV 8.6B
- XP 9.8B
- IPO Year
- ROIV N/A
- XP 2019
- Fundamental
- Price
- ROIV $14.08
- XP $18.87
- Analyst Decision
- ROIV Strong Buy
- XP Strong Buy
- Analyst Count
- ROIV 4
- XP 5
- Target Price
- ROIV $15.50
- XP $23.80
- AVG Volume (30 Days)
- ROIV 6.6M
- XP 8.1M
- Earning Date
- ROIV 11-11-2025
- XP 08-18-2025
- Dividend Yield
- ROIV N/A
- XP 7.31%
- EPS Growth
- ROIV N/A
- XP 18.07
- EPS
- ROIV N/A
- XP 1.67
- Revenue
- ROIV $23,233,000.00
- XP $3,085,301,717.00
- Revenue This Year
- ROIV N/A
- XP $18.06
- Revenue Next Year
- ROIV $281.14
- XP $12.97
- P/E Ratio
- ROIV N/A
- XP $11.29
- Revenue Growth
- ROIV N/A
- XP 6.65
- 52 Week Low
- ROIV $8.73
- XP $10.82
- 52 Week High
- ROIV $14.48
- XP $20.64
- Technical
- Relative Strength Index (RSI)
- ROIV 76.40
- XP 61.55
- Support Level
- ROIV $11.85
- XP $18.21
- Resistance Level
- ROIV $14.48
- XP $19.19
- Average True Range (ATR)
- ROIV 0.42
- XP 0.54
- MACD
- ROIV 0.21
- XP 0.17
- Stochastic Oscillator
- ROIV 86.26
- XP 88.52
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.